Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,380 | -15,287 | -9,711 | -57,107 | -48,203 |
| Depreciation Amortization | 339 | 217 | 124 | 738 | 582 |
| Accounts receivable | -63 | 113 | 118 | -87 | -391 |
| Accounts payable and accrued liabilities | 1,531 | 25 | 156 | -1,087 | -618 |
| Other Working Capital | 2,207 | 2,028 | -208 | -6,047 | -2,540 |
| Other Operating Activity | -9,414 | -3,385 | 867 | 4,081 | 706 |
| Operating Cash Flow | $-26,780 | $-16,289 | $-8,654 | $-59,509 | $-50,464 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -193 | -99 | -2 | -131 | -118 |
| Investing Cash Flow | $-193 | $-99 | $-2 | $-131 | $-118 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,023 | 1,317 | 969 | 55,036 | 1,157 |
| Common Stock Repurchased | -132 | -132 | -132 | -498 | -250 |
| Financing Cash Flow | $4,891 | $1,185 | $837 | $54,538 | $907 |
| Beginning Cash Position | 68,204 | 68,204 | 68,204 | 73,306 | 73,306 |
| End Cash Position | 46,122 | 53,001 | 60,385 | 68,204 | 23,631 |
| Net Cash Flow | $-22,082 | $-15,203 | $-7,819 | $-5,102 | $-49,675 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,780 | -16,289 | -8,654 | -59,509 | -50,464 |
| Capital Expenditure | -193 | -99 | -2 | -132 | -119 |
| Free Cash Flow | -26,973 | -16,388 | -8,656 | -59,641 | -50,583 |